CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Open-market sale HEAD OF RARE DISEASE sold 6,500 shares at $57.70 ($375,050)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $61.36 ($15,340)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $57.19 ($14,298)
- 8-K Event Material agreement · Acquisition or sale completed
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $56.82 ($14,205)
- 8-K Event Other events
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 1,486 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 3,646 shares (to pay taxes)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 250 shares at $59.62 ($14,905)
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 2,743 shares at $62.00 ($170,066)
- 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 1,743 shares (to pay taxes)
- 144 Insider Sale of Securities
Page 13 of 90 · 1,784 filings